METASTATIC SOLID TUMOR
Clinical trials for METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer pill trial halted early
Disease control TerminatedThis early-stage study tested an experimental pill called PRT7732 in people with advanced solid tumors that have a specific genetic mutation (SMARCA4). The main goals were to check safety, find the right dose, and see if the drug shrinks tumors. The study was terminated early, an…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 26, 2026 11:15 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested an experimental drug called TransCon TLR7/8 Agonist, alone or with another drug (pembrolizumab), in people with advanced solid tumors that had stopped responding to standard treatments. The goal was to find a safe dose and check for side effects. The trial was t…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
Experimental combo for rare Gene-Mutated cancers halted early
Disease control TerminatedThis study tested a new drug (PRT3789) combined with the immunotherapy pembrolizumab in people with advanced cancers that have a specific genetic change called SMARCA4. The goal was to see if the combination was safe and could shrink tumors. The study was terminated early after e…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 26, 2026 11:07 UTC
-
Cancer drug trial halted early: no breakthrough for advanced tumors
Disease control TerminatedThis early-stage trial tested a new drug, DCC-3116, alone or with other targeted therapies, in 91 adults with advanced solid tumors (like lung cancer) that have specific gene mutations. The study was terminated, meaning it stopped early, likely due to safety or lack of benefit. T…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 26, 2026 11:06 UTC
-
New cancer combo shows early promise, but trial halted
Disease control TerminatedThis early-phase study tested a new experimental drug, BGB-A3055, alone or with another drug (tislelizumab), in people with advanced solid tumors that had spread. The main goals were to check safety, how the body handles the drug, and whether it shrinks tumors. The study was term…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Cancer drug study halted early: what we know
Disease control TerminatedThis early-stage study tested a new drug, BGB-B3227, alone or with another drug (tislelizumab) in 35 people with advanced solid tumors. The goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 11, 2026 20:47 UTC